AOD-9604 (Anti-Obesity Drug 9604) is a synthetic peptide corresponding to amino acids 176191 of human growth hormone
Preclinical studies in rodent models have evaluated outcomes such as fat oxidation, body-weight change patterns, and metabolic markers tied to fat breakdown and storage
The mishaps can lead to alterations in bodily processes, like weight gain and loss
Frequently Asked Questions Common symptoms include persistent fatigue, weakness, pale skin, pins and needles, a sore tongue and cognitive difficulties such as brain fog or memory problems
Meditation, adequate recovery, and stress reduction support metabolic optimization
To minimize bruising, do not rub the injection site after removing the needle